Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
---|
05/30/2001 | EP1102756A1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss |
05/30/2001 | EP1102754A1 Imidazoles and related compounds as alpha-1a agonists |
05/30/2001 | EP1102744A1 Novel method for preparing optically active alpha-aminonitriles |
05/30/2001 | EP0687176B1 Use of riluzole for treating aids-related neural disorders |
05/30/2001 | CN1297440A Piperidinyl and N-amidinopiperidinyl derivs. |
05/30/2001 | CN1296946A Process for synthesizing allantoin |
05/30/2001 | CN1066444C Nitrogenous derivs. for elemene and their use as anticancer drugs |
05/29/2001 | US6239153 Insulin sensitivity enhancer with squaline synthesis inhibitor, which shows a potent depressive effect on diabetic hyperglycemia, |
05/29/2001 | US6239151 Compounds as inhibitor of tumor necrosis factor alpha release |
05/29/2001 | US6239138 Vitronectin receptor antagonist |
05/29/2001 | US6239137 Salts of aminoimidazole carboxamide and 5 amino or substituted amino 1,2,3-triazole, induce apoptosis, inhibit DNA synthesis and control cyclooxygenase activity |
05/29/2001 | US6238665 Anti-edema agent |
05/29/2001 | CA2325783A1 Ultraviolet-protecting cosmetic compounds containing amino- amidine derivatives and uses |
05/25/2001 | WO2001036660A2 Transition metal complexes attached to a polymer via a flexible chain |
05/25/2001 | WO2001036430A1 Transition metal complexes with bidentate ligand having an imidazole ring |
05/25/2001 | WO2001036403A1 Urea derivatives as anti-inflammatory agents |
05/25/2001 | WO2001036375A1 Aminoalcohol derivatives useful for the treatment of gastrointestinal disorders |
05/25/2001 | WO2001036360A1 Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
05/25/2001 | WO2000039081A3 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
05/25/2001 | CA2391423A1 Polymeric transition metal complexes and uses thereof |
05/24/2001 | US20010001799 Anticoagulant |
05/23/2001 | EP1101759A1 Phenylazole compounds, process for producing the same and drugs for hyperlipemia |
05/23/2001 | EP1100805A1 Medicine nitrate salts |
05/23/2001 | EP1100801A2 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein |
05/23/2001 | EP1100789A1 Substituted benzoylcyclohexandiones |
05/23/2001 | EP1100784A1 Method for the production of n,n'-carbonyl diazoles |
05/23/2001 | EP1100493A1 INDOLE sPLA 2? INHIBITORS |
05/23/2001 | EP1100492A1 INDOLE sPLA 2? INHIBITORS |
05/23/2001 | CN1296475A Process for producing arylsulfenyl halide |
05/23/2001 | CN1066135C Synthesized excitatory amino acid |
05/22/2001 | US6235928 Enzyme inhibitor matrix metalloproteinase family, including collagenase, stromelysin, and gelatinase, the compounds or pharmaceutical compositions |
05/22/2001 | US6235927 Process for the separation of a mixture of enantiomers |
05/22/2001 | US6235910 Process for the preparation of imidazolidine-2, 4-diones |
05/22/2001 | US6235787 Antiinflammatory agents; rheumatic diseases; bone disorders; skin disorders; multiple sclerosis |
05/22/2001 | US6235766 1-(p-thienylbenzyl)imidazoles as agonists of angiotensin (1-7) receptors, processes for their preparation, their use, and pharmaceutical preparations comprising them |
05/17/2001 | WO2001034594A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors |
05/17/2001 | WO2001034580A1 Heterocycle substituted diphenyl leukotriene antagonists |
05/17/2001 | WO2001034578A1 Compounds with anti-helicobacter pylori activity |
05/17/2001 | WO2001034573A1 Compounds |
05/17/2001 | WO2001034147A1 Oral solid preparation |
05/17/2001 | WO2001034135A2 Oncolytic combinations for the treatment of cancer |
05/17/2001 | WO2000039098A9 Synthesis of histamine dihydrochloride |
05/17/2001 | CA2391230A1 Heterocycle substituted diphenyl leukotriene antagonists |
05/17/2001 | CA2390789A1 Oncolytic combinations for the treatment of cancer |
05/17/2001 | CA2390231A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors |
05/16/2001 | EP1099692A1 N,n-substituted cyclic amine derivatives |
05/16/2001 | EP1098885A1 Imidazole compounds and their use as adenosine deaminase inhibitors |
05/16/2001 | EP1098870A2 Nitric esters and nitrate salts of specific drugs |
05/16/2001 | EP1098662A2 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |
05/16/2001 | CN1295473A Use of dexmedetomidine for ICU sedation |
05/15/2001 | US6232342 Protease inhibitors |
05/15/2001 | US6232336 Nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same |
05/15/2001 | US6232330 Therapeutically effective amount of an insulin sensitivity enhancer(pioglitazone,troglitazone and salts) in combination with an aldose reductase inhibitor(tolurestat,epalrestat,imirestat,zenarestat) |
05/15/2001 | US6232328 Non-systemic control of parasites |
05/15/2001 | CA2238978C Retroviral protease inhibiting compounds |
05/10/2001 | WO2001033221A1 Axor35, a g-protein coupled receptor |
05/10/2001 | WO2001032611A1 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
05/10/2001 | WO2001032603A1 Chiral (s- or r-methylphenylglycine) amino acid crystal and method for preparing same |
05/10/2001 | WO2001032173A1 Kainic acid neurocytotoxicity inhibitors |
05/10/2001 | CA2389373A1 Chiral (s- or r-methylphenylglycine) amino acid crystal and method for preparing same |
05/09/2001 | EP1097921A1 Phenylhydrazines |
05/09/2001 | EP1097719A1 NEP inhibitors for the treatment of female sexual dysfunction |
05/09/2001 | EP1097718A1 NPY antagonists for the treatment of female sexual dysfunction |
05/09/2001 | EP1097707A1 Treatment of female sexual dysfunction |
05/09/2001 | EP1097706A1 Phosphodiesterase inhibitors for the treatment of female sexual dysfunction |
05/09/2001 | EP1097141A1 Imidazole derivatives with biphenylsulfonyl substitution, method for preparing them and their use as a drug or diagnostic agent |
05/09/2001 | EP1097140A2 Biphenylsulfonyl-substituted imidazole derivatives, their preparation process, their use as a drug or diagnostic agent and drug containing them |
05/09/2001 | EP1097129A1 N-benzocycloalkyl-amide derivatives and their use as medicaments |
05/09/2001 | CN1294593A Cephalosporines having cyclic aminoguanidine substituents as antibiotics |
05/09/2001 | CN1294582A Novel nucleic acid trangsfer agents, compsns, contg. same and uses |
05/09/2001 | CN1294578A Novel naphthyl-substituted and anilide-substituted sulfonanides |
05/09/2001 | CN1294568A Fluorinating agent, process for producing same, and use thereof |
05/09/2001 | CN1065531C Aminotetrazole derivatives useful as nitric oxide synthase inhibotors |
05/08/2001 | US6229011 N-aroylphenylalanine derivative VCAM-1 inhibitors |
05/08/2001 | US6228942 Dehydration to esterify or amidate surface of oxidized or aminated carbon powder or fiber suspended in solution containing a monomer or polymer having amine, hydroxy, and/or viny ether groups |
05/08/2001 | CA2324484A1 Compounds for the treatment of female sexual dysfunction |
05/08/2001 | CA2323464A1 Compounds for the treatment of female sexual dysfunction |
05/08/2001 | CA2323191A1 Compounds for the treatment of female sexual dysfunction |
05/08/2001 | CA2323183A1 Compounds for the treatment of female sexual dysfunction |
05/08/2001 | CA2027530C W-phenoxy-heterocyclic compounds |
05/03/2001 | WO2001030764A1 1-substituted phenyl-1-(1h-imidazol-4-yl) alcohols, process for producing the same and use thereof |
05/03/2001 | WO2001030763A1 Process for producing optically active naphthalene derivative and optical resolver therefor |
05/03/2001 | WO2001030762A1 Imidazol-4-ylmethanols use as inhibitors of steroid c17-20 lyase |
05/03/2001 | WO2001030761A1 Heterocyclically substituted benzoylguanidine, method for the production thereof, the use thereof as a medicament or means of diagnosis and a medicament containing the same |
05/03/2001 | WO2001030749A1 Novel compounds |
05/03/2001 | WO2001030347A1 Treatment or prevention of hypotension and shock |
05/03/2001 | WO2001030327A2 Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prophylaxis of ischaemic conditions |
05/03/2001 | WO2001030148A1 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
05/03/2001 | WO2001002370B1 Nickel-based reagents for detecting dna and dna-protein contacts |
05/03/2001 | DE19951701A1 Verwendung von 2-Imidazolyl-substituierten Carbinolen zur Herstellung eines Medikaments zur Behandlung oder Prophylaxe von durch ischämischen Zuständen bewirkten Krankheiten Use of 2-imidazolyl-substituted carbinols of manufacturing a medicament for the treatment or prophylaxis of illnesses caused by ischemic conditions |
05/03/2001 | CA2388956A1 Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prophylaxis of ischaemic conditions |
05/03/2001 | CA2388508A1 1-substituted phenyl-1-(1h-imidazol-4-yl) alcohols, process for producing the same and use thereof |
05/03/2001 | CA2388483A1 Process for producing optically active naphthalene derivative and optical resolver therefor |
05/03/2001 | CA2387869A1 Imidazol-4-ylmethanols use as inhibitors of steroid c17-20 lyase |
05/02/2001 | EP1095936A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation |
05/02/2001 | EP1095933A1 Novel N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
05/02/2001 | EP1095275A2 Endogenous constitutively activated g protein-coupled orphan receptors |
05/02/2001 | EP1095024A1 Method for producing carbonyl diimidazoles |
05/02/2001 | EP1095023A1 Diphenylimidazolines |
05/02/2001 | EP1095016A1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |